This paper presents a reappraisal of the blood clotting response (BCR) tests for anticoagulant rodenticides, and proposes a standardised methodology for identifying and quantifying physiological resistance in populations of rodent species. The standardisation is based on the International Normalised Ratio, which is standardised against a WHO international reference preparation of thromboplastin, and allows comparison of data obtained using different thromboplastin reagents. ne methodology is statistically sound, being based on the 50% response, and has been validated against the Norway rat (Rattus norvegicus) and the house mouse (Mus domesticus). Susceptibility baseline data are presented for warfarin, diphacinone, chlorophacinone and couma...
Anticoagulant rodenticide (AR) resistance in Norway rat populations has been a problem for fifty yea...
We investigated the relationship between the severity and incidence of resistance among Norway rats ...
Roughly 50 years ago, the Wisconsin Alumni Research Foundation developed warfarin, the first anticoa...
Blood clotting response (BCR) resistance tests are available for a number of anticoagulant rodentici...
Warfarin resistance was first discovered among Norway rat (Rattus norvegicus) populations in Scotlan...
Anticoagulants rodenticides have already known for over half a century, as effective and safe method...
Warfarin resistance was first discovered among Norway rat (Rattus norvegicus) populations in Scotlan...
Resistance baselines were obtained for the first generation anticoagulant rodenticides chlorophacino...
Warfarin resistance was first discovered among Norway rat (Rattus norvegicus) populations in Scotlan...
Anticoagulant resistance was first discovered in UK Norway rats (Rattus norvegicus Berk.) in 1958 an...
Between 1988 and 1995 populations of rats on agricultural premises were sampled to investigate the d...
Background The house mouse (Mus musculus) is a globally distributed rodent pest species against whi...
A new blood clotting response test was used to determine the susceptibility, to coumatetralyl and br...
Anticoagulant rodenticide (AR) resistance in Norway rat populations has been a problem for fifty yea...
Introduction: Resistance to anticoagulants in Norway rats (Rattus norvegicus) and house mice (Mus do...
Anticoagulant rodenticide (AR) resistance in Norway rat populations has been a problem for fifty yea...
We investigated the relationship between the severity and incidence of resistance among Norway rats ...
Roughly 50 years ago, the Wisconsin Alumni Research Foundation developed warfarin, the first anticoa...
Blood clotting response (BCR) resistance tests are available for a number of anticoagulant rodentici...
Warfarin resistance was first discovered among Norway rat (Rattus norvegicus) populations in Scotlan...
Anticoagulants rodenticides have already known for over half a century, as effective and safe method...
Warfarin resistance was first discovered among Norway rat (Rattus norvegicus) populations in Scotlan...
Resistance baselines were obtained for the first generation anticoagulant rodenticides chlorophacino...
Warfarin resistance was first discovered among Norway rat (Rattus norvegicus) populations in Scotlan...
Anticoagulant resistance was first discovered in UK Norway rats (Rattus norvegicus Berk.) in 1958 an...
Between 1988 and 1995 populations of rats on agricultural premises were sampled to investigate the d...
Background The house mouse (Mus musculus) is a globally distributed rodent pest species against whi...
A new blood clotting response test was used to determine the susceptibility, to coumatetralyl and br...
Anticoagulant rodenticide (AR) resistance in Norway rat populations has been a problem for fifty yea...
Introduction: Resistance to anticoagulants in Norway rats (Rattus norvegicus) and house mice (Mus do...
Anticoagulant rodenticide (AR) resistance in Norway rat populations has been a problem for fifty yea...
We investigated the relationship between the severity and incidence of resistance among Norway rats ...
Roughly 50 years ago, the Wisconsin Alumni Research Foundation developed warfarin, the first anticoa...